These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 32406632)

  • 21. Legal issues regarding gene editing at the beginning of life: an EU perspective.
    De Miguel Beriain I
    Regen Med; 2017 Sep; 12(6):669-679. PubMed ID: 28976851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR -Cas9: a groundbreaking new technique which ushers in new prospects and just as many doubts.
    Napoletano S; Piersanti V; Rallo G
    Clin Ter; 2021; 171(1):e52-e54. PubMed ID: 33346327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preface for genome editing special issue].
    Gu F; Gao C
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1661-1664. PubMed ID: 29082714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recent progresses in CRISPR genome editing in plants].
    Li H; Xie K
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1700-1711. PubMed ID: 29082718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The application of CRISPR/Cas9 genome editing technology in cancer research].
    Wang DY; Ma N; Hui Y; Gao X
    Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
    Ebrahimi V; Hashemi A
    Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology.
    Grant EV
    Food Drug Law J; 2016; 71(4):608-33. PubMed ID: 29140647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CRISPR babies controversy: Responsibility and regulation in the spotlight.
    Meyer M
    EMBO Rep; 2020 Jul; 21(7):e50307. PubMed ID: 32468716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Promise of CRISPR for Human Germline Editing and the Perils of "Playing God".
    Locke LG
    CRISPR J; 2020 Feb; 3(1):27-31. PubMed ID: 32091254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dealing with Patent Fragmentation in Genetics: Can Patent Pools Facilitate the Development of CRISPR Gene-Editing Technology?
    Stasi A; Rodrigues IP
    J Law Med; 2019 Jul; 26(4):866-873. PubMed ID: 31682364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
    Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges and advances of CRISPR-Cas9 genome editing in therapeutics.
    Stellos K; Musunuru K
    Cardiovasc Res; 2019 Feb; 115(2):e12-e14. PubMed ID: 30668679
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genome editing technology and its application in forage legumes].
    Liu H; Meng Y; Niu L; Lin H
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1733-1743. PubMed ID: 29082721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A society-wide conversation is needed about germline genome editing using CRISPR.
    Birney E
    Nat Med; 2024 Jan; 30(1):30-32. PubMed ID: 38177854
    [No Abstract]   [Full Text] [Related]  

  • 39. CRISPR/Cas Genome Editing and Precision Plant Breeding in Agriculture.
    Chen K; Wang Y; Zhang R; Zhang H; Gao C
    Annu Rev Plant Biol; 2019 Apr; 70():667-697. PubMed ID: 30835493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
    Tapscott T; Guarnieri MT; Henard CA
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.